-Bloomberg
HC Wainwright Starts Coverage on This Small-Cap Cancer Focused Stock
HC Wainwright initiated coverage on Tango Therapeutics Inc (NASDAQ:TNGX) with a Buy rating and a price target of $10 per share. Tango…
Related Posts
Here’s Why Cognyte Software Shares Are Crashing Premarket
Cognyte Software Ltd (NASDAQ:CGNT) reported a first-quarter FY23 non-GAAP revenue decline of 24.7% year-on-year to $86.7 million, missing the consensus of…
Pfizer’s ZELJANZ Receives Marketing Authorization In EU For Treatment Of Active Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis
Pfizer Inc. (NYSE:PFE) announced today that the European Commission (EC) has approved XELJANZ® (tofacitinib) for the treatment of active polyarticular juvenile idiopathic arthritis (JIA) and juvenile psoriatic
